Literature DB >> 36110657

Detection of Human PapillomaVirus and its Association with Potentially Malignant Disorders and Oral Squamous Cell Carcinoma: A Retrospective Study.

Anushree Rathore1, Anushree Tiwari2, Maira Nazim3, Anup Kumar Gupta4, Mounica Gande5, Jyothi Krishnakumar6.   

Abstract

Aim: This study was carried out with the objective of recognizing the involvement of human papillomavirus (HPV) in conditions of oral squamous cell carcinoma (OSCC) and oral potentially malignant conditions and lesions. Materials and
Methods: OSCC samples from thirty patients were collected and thirty paraffin-embedded, oral premalignant specimens were collected. It was decided to use as a negative control samples gingiva from healthy individuals who had no prior history of oral proliferative leukoplakia or OSCC. The samples were then processed using a paraffin-embedded tissue block method. Deoxyribonucleic acid will be extracted from the paraffin-embedded tumor sample of sixty case subjects and tested for the presence of HPV DNA using polymerase chain reaction.
Results: In study Group 1, 24 samples were taken from males and 6 from females. In study Group 2, 26 cases were males and 4 were females. In Group 1, 16 cases of moderately differentiated and 14 cases of well differentiated each were present. No case of poorly differentiated were found. There was statistically no significant difference present between male and female when Group 1 and Group 2 was considered. In study Group 1, 0 samples had positive HPV DNA detection, whereas 30 samples had negative HPV DNA detection. In study Group 2, 0 samples had positive HPV DNA detection, whereas 30 samples had negative HPV expression.
Conclusion: According to our findings, certain incidences of OSCC may be linked to HPV, however, this was not the case for all of the cancers. Copyright:
© 2022 Journal of Pharmacy and Bioallied Sciences.

Entities:  

Keywords:  Human papillomavirus; oral squamous cell carcinoma; potential malignant lesions

Year:  2022        PMID: 36110657      PMCID: PMC9469399          DOI: 10.4103/jpbs.jpbs_9_22

Source DB:  PubMed          Journal:  J Pharm Bioallied Sci        ISSN: 0975-7406


INTRODUCTION

One in every 563826 new cases (including 274,850 oral cavity cancers, 159,363 laryngeal cancers, and 52,100 oropharyngeal cancers), as well as the 301,408 fatalities caused by human squamous cell carcinoma (HNSCC), occur each year.[12] Squamous cell carcinomas of oral cavity, oropharynx, larynx, and hypopharynx make up the majority of cases of head-and-neck cancer. There has been an increase in the occurrence of oropharyngeal squamous cell carcinoma (OPSCC), especially among younger males, that involves the palatine and lingual tonsils. Tobacco and alcohol use are two of the most important risk factors for HNSCC.[3] It was first hypothesized in the 1980s that human papillomavirus (HPV), specifically OPSCC, could be a cause of high-grade nonsmall cell lung cancer in people who do not smoke or drink alcohol.[45] More and more evidence from the fields of epidemiology and molecular biology points to the possibility that certain types of high-risk human papillomavirus, particularly types 16 and 18, are to blame for the emergence of certain types of head-and-neck cancer, particularly OPSCC.[67] The rate of detection of HPV in premalignant lesions is believed to raise as the severity of the abnormality of disease increases. Some recent research has shown that HPV is present in Oral Squamous Cell Cancer. To better understand the diagnosis and treatment of oral squamous cell carcinoma (OSCC) and other potentially malignant lesions in the mouth caused by HPV, further study is required.[8910] Therefore, this study was carried out with the objective of recognizing the involvement of HPV in conditions of OSCC and oral potentially malignant conditions and lesions with the help of paraffin-embedded blocks.

MATERIALS AND METHODS

This review was endorsed by the Institutional Ethical Committee of PCDS and RC. OSCC tests from thirty patients were gathered from Jawaharlal Nehru Cancer Hospital and Research Center and thirty paraffin-inserted, oral premalignant examples from the Department of Oral Pathology, People's College of Dental Sciences, PCDS, and RC. Negative control tests were chosen as typical tissue examples from gingiva from patients without a background marked by oral proliferative leukoplakia (OPL) or OSCC. The paraffin-inserted tissue squares of analyzed instances of OSCC related with (n = 20) and without (n = 20) tobacco as well as liquor use and the oral mucosa of solid controls (n = 20) without tobacco or potentially liquor use were gathered from the files of the Department of Oral Pathology and Microbiology, People's College of Dental Sciences, Bhopal. DNA will be extracted from the paraffin-embedded tumor sample of sixty case subjects. The DNA of samples will be tested for the presence of HPV viral DNA [Figure 1] using polymerase chain reaction (PCR).
Figure 1

Thermal cycler polymerase chain reaction

Thermal cycler polymerase chain reaction

Procedure

Weigh 2 g of agarose powder and mix in 100 ml of 1 × TAE buffer (for 2% agarose) Boil with gentle stirring till homogenous clear solution is formed Cool for some time. Add 2 μl of ethidium bromide (0.5 μg/ml) Pour into gel mold and place the comb. Allow to settle for at least 20 min Remove the comb carefully. Keep the gel in electrophoresis unit [Figure 2] (3B BlackBio, Bhopal) containing 1 × TAE buffer (200 ml). The gel should be completely submerged in the buffer
Figure 2

Gel Electrophoresis unit

Red color buffer in the amplified sample will act as loading dye Take 20 μl of this amplified product and add carefully into the wells; Load molecular weight marker in the last well Fix the electrode, turn on the power supply and adjust the current (16A) Run the gel for 2 h Then, take the photo of gel under UV light transilluminator and record the bands using gel documentation system (Major Science, USA) [Figure 3].
Figure 3

UV transilluminator (for gel analysis)

Gel Electrophoresis unit UV transilluminator (for gel analysis)

Single-strand conformation polymorphism

A single-strand conformational polymorphism was studied using (-p32) dCTP-specific activity, 4000 Ci/mmol; BARC, Mumbai, India, radiolabeling of PCR products after thirty cycles of regular amplification. The PCR mix contained (-p32) dCTP. Consequently, 100 L of regular PCR mix with 1 L of (-p32) dCTP was added to, and all other reaction components were left unchanged, for ten samples (10 L each). For 5 min at 95°C, 1 L of radiolabeled PCR product was heat denatured and then refrigerated for 5 min on ice before being mixed with nine volumes (ten times) of denaturing solution (95% formamide, 20-mM ethylenediaminetetraacetic acid (EDTA) pH – 8.,05% xylene cyanol, and. 05% bromophenol blue). It was decided to subject 3 L of this dilute sample to nondenaturing gel electrophoresis in 6% polyacrylamide gel with 10% glycerol. The gel was run in 0.5 XTBE (0.045M Tris borate, 0.001M EDTA pH – 8.0) for 12 h at 200V at 17 ± 1°C in a base sequencing gel device (Stratagene GmbH, Germany). Following a 48 h drying period, the gel was exposed to X-ray film using an intensifying screen and a 70°C temperature setting. The electrophoretic mobility of single-strand DNA bands was examined by making comparisons with controls that were healthy. The following diagram shows an example of this.

RESULTS

There were sixty tissue blocks from the Department of Oral Pathology's archives that were used for this investigation. Group 1: thirty diagnosed cases of OSCC. Group 2: thirty diagnosed cases of premalignancy. Group 3: ten normal oral mucosa.

Gender distribution

In study Group 1, 24 samples were taken from males and 6 from females. In study Group 2, 26 cases were males and 4 were females.

Histopathological grading

In Group 1, 16 cases of moderately differentiated and 14 cases of well differentiated each were present. No case of poorly differentiated was found. Men and women in Group 1 did not show any statistically significant differences [Table 1 for further information]. There was no statistically significant difference between male and female participants in Group 2 [Table 2].
Table 1

Human papillomavirus DNA detection and gender distribution in study Group 1

HPVGenderTotal P

MaleFemale
Positive0001
Negative24630
Total24630

HPV: Human papillomavirus

Table 2

Human papillomavirus DNA detection and gender distribution in study Group 2

HPVGenderTotal P

MaleFemale
Positive000>1
Negative26430
Total26430

HPV: Human papillomavirus

Human papillomavirus DNA detection and gender distribution in study Group 1 HPV: Human papillomavirus Human papillomavirus DNA detection and gender distribution in study Group 2 HPV: Human papillomavirus

Association among study groups (Group 1, 2, and 3) between human papilloma virus and DNA detection

In study Group 1, 0 samples had positive HPV DNA detection, whereas 30 samples had negative HPV DNA detection. In study Group 2, 0 samples had positive HPV DNA detection, whereas 30 samples had negative HPV expression. In no way, shape, or form did the research, Groups 1, 2, and 3 have any connection to HPV DNA.

Association among study groups (Group 1, 2, and 3) between P53 mutations

In study Group 1 and 2, no samples showed the presence of any p53 mutation. In no way, shape, or form were study Groups 1, 2, or 3 linked to a p53 mutation [Table 3].
Table 3

p53 mutation status in study Group 1, 2

p53 mutationStudy groupTotal P

Group 1Group 2
p53 mutation present001>0.5
p53 mutation absent303060
Total303060
p53 mutation status in study Group 1, 2

DISCUSSION

The HPV genome prevalence in OSCC varies from 2.9% to 49.5% because the basal cells are exposed on the oral mucosal surface, this region has the highest HPV risk. Squamous epithelium covers the oral mucosa; hence, it is crucial to examine the link between HPV infection and oral squamous cell cancer (OSCC).[6] There have been several studies showing a correlation between HPV and OSCC, however, the precise nature of this relationship to oral carcinogenesis is still unknown.[11] The goal of this investigation was to look for HPV DNA in OSCC, PMDs, and normal mucosa. Observations on the prevalence of oral HPV in healthy individuals, PMDs, and OSCC have ranged from 0% to 100%, according to various studies.[9] The findings seemed to be influenced by the sample procedures, the patient's characteristics, the detection technologies used, and the anatomical position of the tumors. We used PCR with primers and probes specific to HPV to test thirty OPML and thirty oral SCCs for the presence of HPV DNA, which has been found often in cervical carcinomas. No HPV DNA sequences were found in any of the thirty samples from OSCC and OPMD. In this study Group 1 and 2, no samples showed the presence of any p53 mutation. In no way, shape, or form were study Groups 1, 2, or 3 linked to a p53 mutation. Preliminary results from studies looking at oral cancer samples using PCR-based approaches support this conclusion.[10] According to Carey TE, there was no connection between HPV, OPL, and OSCC, which supported our results. Although HPV was shown to be much more prevalent in OPL than OSCC, Raj, AT et al. believe this might be an early marker of malignant transformation since it was found to be significantly more prevalent in OPL than OSCC. Diversification of the population is also thought to effect rate changes in several ways.[11] OSCC HPV detection rates are 0% in some countries, including India, Brazil, Japan, and Mozambique. Other reported detection rates include 1.54% in Thailand, 6.6% in America, 5% in Mexico, 39.4% in Spain, and 66.7% in Sudan. Study findings using traditional PCR tests in China vary widely, from 2.2% to 74% of the whole sample. There was a modest frequency of HPV (1.1%) in OPMD, according to Ha and colleagues. The variation may be due to differences in the types of samples or detection methods.[891011] SCCs of the oropharynx were more likely to be infected with HPV than those of the oral or larynx. Gingival biopsies have also been shown to contain HPV, which suggests that the gingiva might be a potential reservoir for the virus. Latent HPV infection may be to blame for the presence of HPV in normal oral mucosa. There was no correlation between the prevalence of HPV infection and factors such as gender and age. This is consistent with previous research.[11]

CONCLUSION

HPV may have a role in the development of head-and-neck cancers, according to prior research. Molecular processes have recognized its capacity to disrupt crucial cellular components that regulate cell division and death. According to our findings, certain incidences of OSCC may be linked to HPV, however, this was not the case for all of the cancers.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  9 in total

Review 1.  Reviewing the role of human papillomavirus in oral cancer using the Bradford Hill criteria of causation.

Authors:  A Thirumal Raj; Shankargouda Patil; Archana A Gupta; Chandini Rajkumar; Kamran H Awan
Journal:  Dis Mon       Date:  2018-11-28       Impact factor: 3.800

Review 2.  Recent data about the role of human papillomavirus (HPV) in oncogenesis of head and neck cancer.

Authors:  Fl Bădulescu; Anda Crişan; Adriana Bădulescu; M Schenker
Journal:  Rom J Morphol Embryol       Date:  2010       Impact factor: 1.033

Review 3.  Detection of human papillomavirus in laryngeal squamous cell carcinoma: Systematic review and meta-analysis.

Authors:  Ricardo Ribeiro Gama; André Lopes Carvalho; Adhemar Longatto Filho; Anderson Paulo Scorsato; Rossana V Mendoza López; Jaana Rautava; Stina Syrjänen; Kari Syrjänen
Journal:  Laryngoscope       Date:  2015-11-06       Impact factor: 3.325

Review 4.  Clinical and scientific impact of human papillomavirus on head and neck cancer.

Authors:  Jeffrey M Friedman; Mark J Stavas; Anthony J Cmelak
Journal:  World J Clin Oncol       Date:  2014-10-10

5.  Detection of human papillomavirus 16 and 18 in patients with oral squamous cell carcinoma and potentially malignant oral disorders in South Indian population: A pilot study.

Authors:  Karthika Panneerselvam; A Rameshkumar; K Rajkumar; Ramya Ramadoss
Journal:  J Cancer Res Ther       Date:  2019 Jul-Sep       Impact factor: 1.805

6.  Human papillomavirus in premalignant oral lesions: No evidence of association in a Spanish cohort.

Authors:  Sara Gomez-Armayones; Eduardo Chimenos-Küstner; Antonio Marí; Sara Tous; Rosa Penin; Omar Clavero; Beatriz Quirós; Miguel Angel Pavon; Miren Taberna; Laia Alemany; Octavio Servitje; Marisa Mena
Journal:  PLoS One       Date:  2019-01-16       Impact factor: 3.240

7.  Oral HPV16 Prevalence in Oral Potentially Malignant Disorders and Oral Cavity Cancers.

Authors:  Kai Dun Tang; Lilian Menezes; Kurt Baeten; Laurence J Walsh; Bernard C S Whitfield; Martin D Batstone; Liz Kenny; Ian H Frazer; Gert C Scheper; Chamindie Punyadeera
Journal:  Biomolecules       Date:  2020-02-03

8.  Proliferative Verrucous Leukoplakia Revisited: A Retrospective Clinicopathological Study.

Authors:  Snehashish Ghosh; Roopa S Rao; Manoj K Upadhyay; Karuna Kumari; D Sharathkumar Sanketh; A Thirumal Raj; Sameena Parveen; Yaser Ali Alhazmi; Ankur Jethlia; Shazia Mushtaq; Sachin Sarode; Rodolfo Reda; Shankargouda Patil; Luca Testarelli
Journal:  Clin Pract       Date:  2021-06-01

9.  High Prevalence of Human Papillomavirus Type 18 in Oral Potentially Malignant Disorders in Thailand.

Authors:  Nithi Kaewmaneenuan; Suree Lekawanvijit; Surawut Pongsiriwet; Vuttinun Chatupos; Anak Iamaroon
Journal:  Asian Pac J Cancer Prev       Date:  2021-06-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.